Business Description
DocCheck AG
ISIN : DE000A1A6WE6
Description
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.59 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | 0.49 | |||||
| Interest Coverage | 17.55 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.9 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.2 | |||||
| 3-Year EBITDA Growth Rate | 26.6 | |||||
| 3-Year EPS without NRI Growth Rate | 19.7 | |||||
| 3-Year Book Growth Rate | 20.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.64 | |||||
| 9-Day RSI | 51.12 | |||||
| 14-Day RSI | 50.21 | |||||
| 6-1 Month Momentum % | -2.19 | |||||
| 12-1 Month Momentum % | -28.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | |||||
| Quick Ratio | 2.16 | |||||
| Cash Ratio | 1.11 | |||||
| Days Inventory | 55.59 | |||||
| Days Sales Outstanding | 46.18 | |||||
| Days Payable | 41.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 8.24 | |||||
| Dividend Payout Ratio | 0.76 | |||||
| 3-Year Dividend Growth Rate | 35.7 | |||||
| Forward Dividend Yield % | 5.49 | |||||
| 5-Year Yield-on-Cost % | 19.25 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 9.32 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.21 | |||||
| Operating Margin % | 11.53 | |||||
| Net Margin % | 10.23 | |||||
| FCF Margin % | 6.32 | |||||
| ROE % | 16.09 | |||||
| ROA % | 10.36 | |||||
| ROIC % | 13.12 | |||||
| ROC (Joel Greenblatt) % | 45.99 | |||||
| ROCE % | 19.86 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.84 | |||||
| PE Ratio without NRI | 9.22 | |||||
| Shiller PE Ratio | 9.57 | |||||
| Price-to-Owner-Earnings | 8.13 | |||||
| PEG Ratio | 0.26 | |||||
| PS Ratio | 0.8 | |||||
| PB Ratio | 1.26 | |||||
| Price-to-Tangible-Book | 1.27 | |||||
| Price-to-Free-Cash-Flow | 12.66 | |||||
| Price-to-Operating-Cash-Flow | 8.32 | |||||
| EV-to-EBIT | 4.24 | |||||
| EV-to-EBITDA | 3.14 | |||||
| EV-to-Revenue | 0.64 | |||||
| EV-to-FCF | 10.18 | |||||
| Price-to-Projected-FCF | 0.62 | |||||
| Price-to-DCF (Earnings Based) | 0.24 | |||||
| Price-to-DCF (FCF Based) | 0.93 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.34 | |||||
| Price-to-Graham-Number | 0.72 | |||||
| Price-to-Net-Current-Asset-Value | 3.83 | |||||
| Earnings Yield (Greenblatt) % | 23.58 | |||||
| FCF Yield % | 7.92 | |||||
| Forward Rate of Return (Yacktman) % | 26.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DocCheck AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 57.538 | ||
| EPS (TTM) (€) | 1.16 | ||
| Beta | 0.64 | ||
| Volatility % | 34.92 | ||
| 14-Day RSI | 50.21 | ||
| 14-Day ATR (€) | 0.178616 | ||
| 20-Day SMA (€) | 9.0075 | ||
| 12-1 Month Momentum % | -28.4 | ||
| 52-Week Range (€) | 7.7 - 13.5 | ||
| Shares Outstanding (Mil) | 5.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DocCheck AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DocCheck AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
DocCheck AG Frequently Asked Questions
What is DocCheck AG(XTER:AJ91)'s stock price today?
The current price of XTER:AJ91 is €9.05. The 52 week high of XTER:AJ91 is €13.50 and 52 week low is €7.70.
When is next earnings date of DocCheck AG(XTER:AJ91)?
The next earnings date of DocCheck AG(XTER:AJ91) is .
Does DocCheck AG(XTER:AJ91) pay dividends? If so, how much?
The Dividend Yield %  of DocCheck AG(XTER:AJ91) is 8.24% (As of Today), Highest Dividend Payout Ratio of DocCheck AG(XTER:AJ91) was 1.01. The lowest was 0.06. And the median was 0.7. The  Forward Dividend Yield % of DocCheck AG(XTER:AJ91) is 5.49%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers